Ainsworth Institute Joins New Clinical Trial on Complex Regional Pain Syndrome (CRPS)
The Ainsworth Institute is proud to announce is has joined the CREATE-1 Study: CRPS Treatment Evaluation 1 Study - sponsored by Axsome Therapeutics, Inc. This is an FDA approved trial studying the effects of a new groundbreaking oral medication to treat CRPS. Enrollment will start shortly.